Lautan Luas Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Lautan Luas Tbk. trades at Rp845 (market cap 1.31T, 48.6K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Lautan Luas Tbk. is far larger — about 2.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 48.6K). Which is the better fit depends on your goals.
| LTLS | PRDL | |
|---|---|---|
Market Cap | 1.31T | 470.58B |
Volume | 48.6K | 28.43M |
Lot | 486 | 284.34K |
Turnover | 40.94M | 7.8B |
Average Price | 842.48 | 274.19 |
Value | 40.94M | 7.8B |
Indicative Equilibrium Price | 850 | 270 |
Indicative Equilibrium Volume | 32 | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Lautan Luas Tbk (the Company) was established under the name of Persekutuan Andil Maskapai Dagang dan Industri Lim Teck Lee Coy Ltd (Indonesia) based on notarial deed No. 75 dated January 18, 1951 of Raden Mas Soerojo. PT. Lautan Luas is a distributor and manufacturer - specialty and basic chemical.
Read more on LTLS →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →